Cargando…
Targeted therapy for sarcomas
Sarcomas are tumors of mesenchymal origin that make up approximately 1% of human cancers. They may arise as primary tumors in either bone or soft tissue, with approximately 11,280 soft tissue tumors and 2,650 bone tumors diagnosed each year in the United States. There are at least 50 different subty...
Autores principales: | Forscher, Charles, Mita, Monica, Figlin, Robert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3962319/ https://www.ncbi.nlm.nih.gov/pubmed/24669185 http://dx.doi.org/10.2147/BTT.S26555 |
Ejemplares similares
-
Aldoxorubicin: a tumor-targeted doxorubicin conjugate for relapsed or refractory soft tissue sarcomas
por: Gong, Jun, et al.
Publicado: (2018) -
Apatinib as targeted therapy for sarcoma
por: Li, Feng, et al.
Publicado: (2018) -
Targeted Therapy in Ewing Sarcoma
por: Lissat, A., et al.
Publicado: (2012) -
Targeted Therapy of Ewing's Sarcoma
por: Subbiah, Vivek, et al.
Publicado: (2011) -
A Rare Finding of a BRAF Mutation in Renal Cell Carcinoma with Response to BRAF-Directed Targeted Therapy
por: Banerjee, Natasha, et al.
Publicado: (2016)